Skip to main content
. 2020 Feb 3;11(8):2022–2031. doi: 10.7150/jca.38981

Table 3.

Correlation between PKM2, CD206 and clinicopathologic features of PDAC

Factor PKM2 P value CD206 P value
Negative Positive Negative Positive
Gender
Male 24 27 0.807 23 28 0.93
Female 13 13 12 14
Age
≥60 27 24 0.2291 25 26 0.379
<60 10 16 10 16
T stage
T3 29 28 0.402 25 32 0.635
≤T2 8 12 10 10
N stage
N0 18 17 0.298 10 25 0.007
N1 19 23 25 17
M stage
M0 36 37 0.664 33 40 1
M1 1 3 2 2
TMN stage
≥II 24 39 0.0002 27 36 0.331
I 13 1 8 6
Tumor sites
Head/Neck 17 22 0.137 18 22 0.934
Body/Tail 20 18 17 20
Nerve invasion
Yes 22 20 0.698 25 24 0.194
No 15 20 10 18
Vascular invasion
Yes 9 1 0.012 2 8 0.164
No 28 39 33 34
Nuclear grade
III 12 24 0.056 13 13 0.567
≤II 35 16 22 29